We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+16.66%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$213M
AUM Growth
+$32.7M
Cap. Flow
+$5.62M
Cap. Flow %
2.65%
Top 10 Hldgs %
40.38%
Holding
46
New
5
Increased
12
Reduced
13
Closed
7

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$13.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.57M
3
ICLR icon
Icon
ICLR
+$2.97M
4
GMED icon
Globus Medical
GMED
+$2.57M
5
MRNA icon
Moderna
MRNA
+$2.13M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$3.89M
2
JNJ icon
Johnson & Johnson
JNJ
+$3.88M
3
MDT icon
Medtronic
MDT
+$2.42M
4
TMO icon
Thermo Fisher Scientific
TMO
+$2.12M
5
UNH icon
UnitedHealth
UNH
+$2.12M

Sector Composition

Rank Sector Weight
1 Healthcare 93.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$14.5M 6.83%
175,000
+163,716
+1,451% +$13.3M
BSX icon
2
Boston Scientific
BSX
$71.5B
$8.56M 4.03%
185,000
– –
SYK icon
3
Stryker
SYK
$130B
$8.56M 4.02%
35,000
+4,500
+15% +$1.02M
HCA icon
4
HCA Healthcare
HCA
$89.5B
$8.4M 3.95%
35,000
-7,500
-18% -$1.68M
THC icon
5
Tenet Healthcare
THC
$21.1B
$8.05M 3.79%
165,000
+45,000
+38% +$2.08M
ISRG icon
6
Intuitive Surgical
ISRG
$134B
$7.96M 3.74%
30,000
– –
UHS icon
7
Universal Health Services
UHS
$10.5B
$7.75M 3.64%
55,000
-10,000
-15% -$1.18M
ZBH icon
8
Zimmer Biomet
ZBH
$18.4B
$7.65M 3.6%
60,000
– –
BAX icon
9
Baxter International
BAX
$14.2B
$7.65M 3.6%
150,000
+30,000
+25% +$1.61M
NVO
10
Novo Nordisk
NVO
$209B
$6.77M 3.18%
100,000
+20,000
+25% +$1.17M
HUM icon
11
Humana
HUM
$46.2B
$6.66M 3.13%
13,000
+2,500
+24% +$1.31M
CI icon
12
Cigna
CI
$74.6B
$6.63M 3.12%
20,000
-5,000
-20% -$1.58M
LLY icon
13
Eli Lilly
LLY
$1.06T
$6.4M 3.01%
17,500
– –
BMRN icon
14
BioMarin Pharmaceuticals
BMRN
$12.4B
$6.21M 2.92%
60,000
+5,000
+9% +$469K
TMO icon
15
Thermo Fisher Scientific
TMO
$220B
$6.06M 2.85%
11,000
-4,000
-27% -$2.12M
A icon
16
Agilent Technologies
A
$41.2B
$5.99M 2.81%
40,000
-10,000
-20% -$1.43M
ACHC icon
17
Acadia Healthcare
ACHC
$2.94B
$5.76M 2.71%
70,000
– –
MCK icon
18
McKesson
MCK
$101B
$5.63M 2.65%
15,000
-2,500
-14% -$932K
CAH icon
19
Cardinal Health
CAH
$55.4B
$5.38M 2.53%
70,000
-10,000
-13% -$760K
DHR icon
20
Danaher
DHR
$144B
$5.31M 2.5%
22,560
-5,640
-20% -$1.31M
WAT icon
21
Waters Corp
WAT
$39.9B
$5.14M 2.42%
15,000
– –
EHC icon
22
Encompass Health
EHC
$12.4B
$5.08M 2.39%
85,000
– –
COR icon
23
Cencora
COR
$61.2B
$4.97M 2.34%
30,000
– –
ABT icon
24
Abbott
ABT
$187B
$4.94M 2.32%
45,000
+15,000
+50% +$1.55M
SGRY icon
25
Surgery Partners
SGRY
$2.03B
$4.6M 2.16%
165,000
+26,391
+19% +$699K
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q4 2022 Portfolio in Review

As of Q4 2022, Sivik Global Healthcare held 46 positions worth $213M, up 18% from $180M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sivik Global Healthcare's Q4 2022 filing shows 5 new, 12 increased, 13 reduced and 7 closed positions. Its largest new stake was Vertex Pharmaceuticals: 15,000 shares worth $4.33M. The largest sale was Centene, an estimated $3.89M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 100% a quarter earlier.

  • Sivik Global Healthcare's largest Q4 2022 buy was Vertex Pharmaceuticals: 15,000 shares worth $4.33M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q4 2022, an estimated $13.3M increase.
  • Sivik Global Healthcare's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $3.88M.
  • Sivik Global Healthcare fully exited Centene in Q4 2022, selling an estimated $3.89M.
  • Sivik Global Healthcare's ten largest holdings make up 40% of its $213M portfolio in Q4 2022.
  • Sivik Global Healthcare opened 5 new positions and closed 7 in Q4 2022.
  • Sivik Global Healthcare's portfolio value rose 18% quarter-over-quarter to $213M.

Based on Sivik Global Healthcare's 13F filing for Q4 2022, filed 8 Feb 2023.